Drug application
LOPINAVIR AND RITONAVIR (LOPINAVIR, RITONAVIR)
Drugs@FDA ANDA 207407 · LANNETT CO INC
Key facts
| Drug name | LOPINAVIR AND RITONAVIR |
|---|---|
| Active ingredients | LOPINAVIR, RITONAVIR |
| Application type | ANDA |
| Application number | 207407 |
| Company | LANNETT CO INC |
| Dosage forms | SOLUTION, ORAL |
| Strength | 80MG/ML;20MG/ML |
| Marketing status | Discontinued |
| TE codes | AA |
| Reference listed drug | No |
| Latest submission status date | Dec 27, 2016 |
At a glance
- 1–9 Submissions
- 1–9 Supplements
- 1–9 Label versions
- 1–9 Products
- 1–9 Therapeutic equivalents
- Yes FDA letters on file
- No FDA reviews on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: